Previous Article | Next Article ![]()
Appl. Environ. Microbiol., 11 1997, 4272-4281, Vol 63, No. 11
HG Wetzstein, N Schmeer and W Karl
The degradation of enrofloxacin, a fluoroquinolone antibacterial drug used
in veterinary medicine, was investigated with the brown rot fungus
Gloeophyllum striatum. After 8 weeks, mycelia suspended in a defined liquid
medium had produced 27.3, 18.5, and 6.7% 14CO2 from [14C]enrofloxacin
labeled either at position C-2, at position C-4, or in the piperazinyl
moiety, respectively. Enrofloxacin, applied at 10 ppm, was transformed into
metabolites already after about 1 week. The most stable intermediates
present in 2-day-old supernatants were analyzed by high-performance liquid
chromatography combined with electrospray ionization mass spectrometry.
Eight of 11 proposed molecular structures could be confirmed by 1H nuclear
magnetic resonance spectroscopy or by cochromatography with reference
compounds. We identified (i) 3-, 6-, and 8-hydroxylated congeners of
enrofloxacin, which have no or only very little residual antibacterial
activity; (ii) 5,6- (or 6,8-), 5,8-, and 7,8-dihydroxylated congeners,
which were prone to autoxidative transformation; (iii) an isatin-type
compound as well as an anthranilic acid derivative, directly demonstrating
cleavage of the heterocyclic core of enrofloxacin; and (iv)
1-ethylpiperazine, the 7-amino congener, and desethylene-enrofloxacin,
representing both elimination and degradation of the piperazinyl moiety.
The pattern of metabolites implies four principle routes of degradation
which might be simultaneously employed. Each route, initiated by either
oxidative decarboxylation, defluorination, hydroxylation at C-8, or
oxidation of the piperazinyl moiety, may reflect an initial attack by
hydroxyl radicals at a different site of the drug. During chemical
degradation of [4-14C]enrofloxacin with Fenton's reagent, five confirmatory
metabolites, contained in groups i and iv, were identified. These findings
provide new evidence in support of the hypothesis that brown rot fungi may
be capable of producing hydroxyl radicals, which could be utilized to
degrade wood and certain xenobiotics.
Copyright © 1997, American Society for Microbiology
Degradation of the fluoroquinolone enrofloxacin by the brown rot fungus Gloeophyllum striatum: identification of metabolites
Animal Health Research, Bayer AG, Leverkusen, Germany.
This article has been cited by other articles:
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|